Papp Krisztián

senior research fellow

PhD (Eötvös Loránd University, Budapest, 2008)

Biography:

I'm an immunologist with more than 10 years of wet lab experience who turned his focus to data science. I'm interested in reproducible data analysis on large datasets (protein microarray, next-generation sequencing...)

Work experience:
* Eötvös Loránd University. (2017 -> ) Department of Physics of Complex Systems; Senior Research Fellow
* Hungarian Academy of Sciences (2007-2017 with interruptions) MTA-ELTE Immunology Research Group
* Diagnosticum Zrt. (2010-2012) 13 months part-time & 8 months full-time; Developer engineer
* Magyary Zoltán Higher Educational Public Foundation (2009 –2010) 12 months; Workplace: Eötvös Loránd University, Department of Immunology

Abroad positions:
* KTH-Royal Institute of Technology, SciLifeLab Stockholm, Sweden ; 2013 (1 month) & 2012 (3 months) Visiting Scholar, EFIS Scholarship
* University of Pennsylvania, Protein Chemistry Laboratory, Philadelphia, USA; 2004 – 2005 (10 months) & 2002 (2 months) Visiting Scholar

Patents:
* József Prechl, Krisztián Papp: Measurement of complement activation products on antigen arrays Publication number: WO2008/007159 (accepted)
* József Prechl, Krisztián Papp, Zoltán Szittner: Method for the analysis of immunoreactivity, and a device suitable for carrying out the method Publication number: WO/2015/019120 (accepted)

Grants:
* 2016 János Gergely medallion and scholarship (Hungarian Immunological Society)
* 2011 János Bolyai Scientific Award (Hungarian Academy of Sciences)
* 2010 Outstanding PhD/DLA work in the field of experimental medical science (Magyary Zoltán Higher Educational Public Foundation)
* 2009 Academic Young Scientist Award (Hungarian Academy of Sciences)
* 2008 The Scopus Award for Biochemistry
* 2007 & 2010 Bio-Science Award
* 2003 Excellent Student of the Faculty Award

Links to associated scientific database profiles:

• Publications in MTMT
• Publications in ORCID
• Publications in Scopus
• Publications in Google Scholar

Selected publications of recent years:

1. A clonal expression biomarker associates with lung cancer mortality; D Biswas, NJ Birkbak, R Rosenthal, CT Hiley, EL Lim, K Papp, S Boeing, ... Nature medicine 25 (10), 1540-1548
2. Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage; A Fluckiger, R Daillere, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ... Science 369 (6506), 936-942
3. Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma; A Gokuldass, A Draghi, K Papp, TH Borch, M Nielsen, MCW Westergaard, ... Cancers 12 (11), 3344
4. Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens; A Draghi, CA Chamberlain, S Khan, K Papp, M Lauss, S Soraggi, ... Frontiers in Immunology 12, 705422
5. Complement factor H-related proteins FHR1 and FHR5 interact with extracellular matrix ligands, reduce factor H regulatory activity and enhance complement activation; A Papp, K Papp, B Uzonyi, M Cserhalmi, ÁI Csincsi, Z Szabó, Z Bánlaki, ... Frontiers in Immunology 13
6. Identification of mutations in SARS-CoV-2 PCR primer regions; A Mentes, K Papp, D Visontai, J Stéger, I Csabai, A Medgyes-Horváth, ... Scientific Reports 12 (1), 18651